Lab Automation Market by Product, Automation Type, Application, End User

List of Tables

[188 Pages Report] The Lab Automation Market size was estimated at USD 5.83 billion in 2023 and expected to reach USD 6.29 billion in 2024, at a CAGR 8.30% to reach USD 10.20 billion by 2030.

Lab automation includes the utilization of technology to perform experiments and procedures in the laboratory with minimal human intervention. It encompasses a variety of platforms, software, and tools to enhance efficiency, accuracy, and productivity in laboratory settings. The purpose is to automate mundane, repetitive tasks, allowing scientists and researchers to focus on more complex and innovative work. Increased demand for high-throughput screening that involves rapidly conducting millions of chemical, genetic, or pharmacological tests is driving the growth of the lab automation market. Growing emphasis on data accuracy and reproducibility with the rising adoption of digital technologies across laboratories is driving the growth of the market. The high initial investment required for setting up an automated laboratory system hampers the market growth. Continuous integration of advanced technologies to improve the efficiency of lab automation solutions is expected to create opportunities for market growth. The evolution of technologies such as liquid handling systems, robotics, and data analytics tools that contribute to the efficiency of lab automation systems improve precision, and reduce the possibilities of human error is expected to create a platform for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 5.83 billion
Estimated Year [2024]	USD 6.29 billion
Forecast Year [2030]	USD 10.20 billion
CAGR (%)	8.30%

Product: Growing usage of automated liquid handlers to manipulate liquids precisely

Automated liquid handlers are designed to manipulate liquids precisely. They are essential in laboratories for tasks such as sample preparation, reagent addition, and dilutions, significantly reducing manual effort and increasing throughput. Automated plate handlers are systems that automate the processing of microplates used in various laboratory applications. They transport, store, and sort these plates, streamlining workflows in high-throughput environments such as drug discovery. Automated storage & retrieval offers a solution for efficiently storing and retrieving samples or compounds. By automating these tasks, labs can manage vast collections of biological or chemical samples more effectively, ensuring better sample integrity and faster access when needed. Robotic arms in labs mimic the movements of a human arm and are capable of performing a wide range of tasks, from simple repetitive actions including, capping and decapping tubes to more complex manipulations. They are customizable and can be integrated with other lab technologies for seamless automation. Software solutions are the backbone of lab automation, enabling the integration and management of automated systems and equipment. They provide the user interface for controlling automation workflows and analyzing the vast amount of data generated. The chromatography data system (CDS) manages and analyzes data from chromatography instruments. CDSs streamline the process of collecting, analyzing, and reporting chromatography data. Electronic lab notebooks (ELN) are digital versions of traditional lab notebooks. They allow scientists to record experiments, processes, and results in an electronic format, fostering better documentation and data sharing. Laboratory information management system (LIMS) manages samples, laboratory users, instruments, and standards. It ensures quality control and facilitates the efficient flow of samples and data through the lab. Laboratory information systems (LIS) are similar to LIMS, focused on the processing and management of data related to medical and clinical laboratories. It helps organize, store, and retrieve patient-related laboratory data. A scientific data management system (SDMS) collects and catalogs unstructured scientific data, making it searchable and shareable. It supports compliance with data integrity and regulatory requirements.

End User: High potential of lab automation solutions across biotechnology & pharmaceutical companies for streamlining workflows

Biotechnology & pharmaceutical companies are at the forefront of adopting lab automation solutions, primarily driven by the need to speed up the drug discovery and development process. Automation helps in streamlining workflows, such as screening of compounds, genomics, and proteomics studies, by enabling high-throughput processes that significantly reduce the time and resources needed for experimental trials. Moreover, automation ensures the reproducibility and reliability of the data, which are critical in regulatory submissions and the commercialization of pharmaceutical products. The primary objective within hospitals & diagnostic laboratory settings is to enhance patient care through timely and accurate diagnostic testing. Lab automation plays a critical role in handling large volumes of patient samples, reducing manual errors, and delivering faster results. Automated systems in these environments include equipment for sample sorting, biochemistry analysis, and molecular diagnostics. These advancements improve workflow efficiency, allow for better resource allocation, and contribute to improved patient outcomes by enabling quicker diagnosis and treatment. Research & academic institutes utilize lab automation for a broad range of applications, from basic biological research to advanced studies in fields including, genetics and biomedical engineering. Automation supports these activities by offering precise control over experimental conditions, improving the reproducibility of scientific experiments, and enabling the analysis of large datasets that would be impractical to manage manually. This not only accelerates the pace of academic research but also enhances the quality and credibility of the findings, promoting further scientific advancements.

Regional Insights

In the Americas, the lab automation market is experiencing robust growth, primarily driven by advanced healthcare infrastructure, significant investment in R&D by pharmaceutical and biotech companies, and a strong focus on innovation. The United States stands out as a pivotal market, owing to its large-scale adoption of automated systems in diagnostics, drug discovery, and genomic research. Government initiatives and funding in life sciences research further fuel the market's expansion in this region. The APAC region is witnessing rapid growth in the lab automation market, attributed to its expanding pharmaceutical sector, rising investments in healthcare infrastructure, and growing emphasis on research and development. Countries including, China, Japan, and India are at the forefront, leveraging lab automation technologies to cater to their vast populations' healthcare needs. The region's commitment to adopting new technologies and increasing healthcare expenditure are key factors propelling the market forward. The lab automation market in EMEA is diversified and has a strong presence in developed and emerging economies. Europe leads in this region, driven by its well-established pharmaceutical and biotech industries and substantial government and private funding for research and innovation. The Middle East and Africa are gradually catching up, with an increasing focus on enhancing healthcare services and research capabilities. The growth in this region is also supported by a growing awareness of the benefits of lab automation in improving diagnostic accuracy and efficiency.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Lab Automation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lab Automation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Lab Automation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuris Instruments, Agilent Technologies, Inc., Aurora Biomed Inc., Automata Technologies Limited, Awareness Technology, Inc., Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biochrom by Harvard Bioscience, Inc., Biohit Oyj, bioMerieux SA, BMG Labtech GmbH, Brooks Automation, Inc., Bruker Corporation, Byonoy GmbH, Cerner Corporation by Oracle Corporation, Corning Incorporated, CTK Biotech, Inc., Danaher Corporation, Dendi, Inc., Dynex Technologies, Inc., Endress+Hauser Group Services AG, Enzo Life Sciences, Inc., Eppendorf SE, F. Hoffmann-La Roche Ltd., Formulatrix, Inc., General Biologicals Corporation, Hamilton Company, Hudson Robotics, Inc., JASCO Corporation, Labguru by Biodata Inc, LabVantage Solutions Inc., LabWare, Inc., LigoLab Information System, Mecademic Robotics, Merck KGaA, Orchard Software Corporation, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Rayto Life and Analytical Sciences Co.,Ltd., Siemens AG, Strateos, Inc., Synchron Lab Automation by MolGen, Tecan Trading AG, Thermo Fisher Scientific Inc., Uncountable Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Lab Automation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Equipment
  - Automated Liquid Handlers
  - Automated Plate Handlers
  - Automated Storage & Retrieval
  - Robotic Arms

Services
- Installation & Commissioning
- Maintenance & Upgrades
- System Integration

Software
- Chromatography Data System
- Electronic Lab Notebook
- Laboratory Information Management System
- Laboratory Information System
- Scientific Data Management System

Automation Type
- Modular Automation
- Total Lab Automation

Application
- Clinical Diagnostics
- Drug Discovery
- Genomics
- Microbiology
- Proteomics

End User
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Lab Automation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lab Automation Market?

3. What are the technology trends and regulatory frameworks in the Lab Automation Market?

4. What is the market share of the leading vendors in the Lab Automation Market?

5. Which modes and strategic moves are suitable for entering the Lab Automation Market?

Product Code: MRR-EA6D0A205BEC

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increased need for high-throughput screening across pharmaceutical companies
  - 5.1.1.2. Growing emphasis on data accuracy and reproducibility by research centers
  - 5.1.1.3. Rising government support for the adoption of automation and digital technologies across the pharmaceutical sector
- 5.1.2. Restraints
  - 5.1.2.1. High Initial Investment associated with the integration of lab automation solutions
- 5.1.3. Opportunities
  - 5.1.3.1. Continuous integration of novel technologies in lab automation solutions that improve efficiency
  - 5.1.3.2. Stringent government regulations around laboratory practices and data integrity
- 5.1.4. Challenges
  - 5.1.4.1. Data security and privacy issues with lab automation solutions
5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing usage of automated liquid handlers to manipulate liquids precisely
- 5.2.2. End User: High potential of lab automation solutions across biotechnology & pharmaceutical companies for streamlining workflows
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Lab Automation Market, by Product

6.1. Introduction
6.2. Equipment
6.3. Services
6.4. Software

7. Lab Automation Market, by Automation Type

7.1. Introduction
7.2. Modular Automation
7.3. Total Lab Automation

8. Lab Automation Market, by Application

8.1. Introduction
8.2. Clinical Diagnostics
8.3. Drug Discovery
8.4. Genomics
8.5. Microbiology
8.6. Proteomics

9. Lab Automation Market, by End User

9.1. Introduction
9.2. Biotechnology & Pharmaceutical Companies
9.3. Hospitals & Diagnostic Laboratories
9.4. Research & Academic Institutes

10. Americas Lab Automation Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Lab Automation Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Lab Automation Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Agilent Technologies Inc. Launches Revolutionary ADS 2 for Enhanced Laboratory Efficiency
- 13.3.2. Carbon Unveils Its Automatic Operation Suite to Enhance Efficiency and Precision
- 13.3.3. Strategic Partnership Elevates European Lab Automation Landscape
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio